# Evaluating the Effect of Food on Absorption of Megace ES

> **NCT00638079** · PHASE1 · COMPLETED · sponsor: **Endo Pharmaceuticals** · enrollment: 24 (actual)

## Conditions studied

- Pharmacokinetics
- Bioavailability
- Absorption

## Interventions

- **DRUG:** Megestrol acetate oral suspension 625 mg/5 mL
- **DRUG:** Megestrol acetate oral suspension 625 mg/5 mL

## Key facts

- **NCT ID:** NCT00638079
- **Lead sponsor:** Endo Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2006-07
- **Final completion:** 2006-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-04-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00638079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00638079, "Evaluating the Effect of Food on Absorption of Megace ES". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00638079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*